Editorial Policies
Our Editorial Management System maintains high quality in the online manuscript submission, review and tracking procedures. Editorial board members evaluate manuscripts solely on the basis of originality and significance to journals scope without regard to ethnic origin, citizenship and institutional affiliation. Journal decisions on acceptance and publication are not determined by agencies and any other policies outside the journal. Journal of Pharmaceutical Research and Innovation Editor-in-Chief has complete authority on the entire timing of publication of your original work. Editorial members along with eminent scholars conduct the review process. Two independent reviewers’ approval followed by the editor, is required for the acceptance of any manuscript.
Confidentiality: Editor-in-Chief and editorial board members must not reveal any evidence and information about the submitted manuscript to any person other than the reviewers, corresponding author, potential reviewers, editorial advisers and the publisher as appropriate.
Disclosure and Conflict of Interest: Editor-in-Chief and editorial board members must not use unpublished materials and information disclosed in a submitted manuscript for their personal research purposes. Ideas and information obtained by editors after handling the document will be held confidential, and not used for their own benefit. Editors may prevent themselves in cases of manuscripts that have conflicts of interest resulting from collaborative/competitive/relationships with any of the organizations/institutions/authors associated with the paper and may ask another editorial member to handle the manuscript.
Publication Decisions: Editor-in-Chief and editorial board members guarantee that all manuscripts submitted are being considered for publication and undergo peer-review process by at least two potential reviewers’ experts in the field of pharmaceutical sciences and research. Editor-in-Chief may confer with other editorial board members/reviewers responsible for deciding manuscript acceptance and publication based on the reviewer’s comments, scope, significance to researchers and readers, validation of work, plagiarism and copyright infringement. The Editor-in-Chief may discuss with other editors or reviewers in making this decision.
Involvement in Decisions: Editorial board members would take responsive actions when ethical concerns are raised respectively for a submitted manuscript or published articles. In any case of suspected misconduct and unethical publishing behaviour, even though exposed after publication, it would still be looked into. Upon investigation and discovery that the ethical concern is well-founded, retraction/correction/expression of concern is appropriate, it would be published in the journal.
Publication Ethics & Publication Malpractice Statement: Journal of Pharmaceutical Research and Innovation is committed to follow ethical standards in its own editorial policy. Our Editorial members are dedicated to ensure a transparent peer review process and committed to make fair & unbiased decisions. We are seriously concerned about instances of misconduct and plagiarism in academic publishing. To be aware of such challenges and develop strategies is an indispensable part of publication and we expect similar awareness from our peer reviewers. We follow best-practice guidelines and recommendations on ethical behaviour for the conduct, reporting, editing and publication of original work in journals.